13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001856083-25-000002
Total Value
$3.09B
Positions
69
Other Managers
0
Confidential Omitted
No
Holdings (69)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 2,000,000 | $263.8M | 8.54% |
| 2 | GUARDANT HEALTH INC | GH | 5,443,721 | $231.9M | 7.51% |
| 3 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 17,791,486 | $230.8M | 7.47% |
| 4 | IMMUNOVANT INC | IMVT | 9,500,000 | $162.4M | 5.26% |
| 5 | PROTAGONIST THERAPEUTICS INC | PTGX | 3,000,000 | $145.1M | 4.70% |
| 6 | IONIS PHARMACEUTICALS INC | IONS | 4,564,207 | $137.7M | 4.46% |
| 7 | AKERO THERAPEUTICS INC | 00973Y108 | 3,210,270 | $130.0M | 4.21% |
| 8 | CYTOKINETICS INC | CYTK | 3,073,853 | $123.5M | 4.00% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 5,000,000 | $109.3M | 3.54% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 14,294,420 | $104.8M | 3.39% |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 2,800,000 | $96.8M | 3.13% |
| 12 | TARSUS PHARMACEUTICALS INC | TARS | 1,484,266 | $76.2M | 2.47% |
| 13 | VIRIDIAN THERAPEUTICS INC | VRDN | 5,380,449 | $72.5M | 2.35% |
| 14 | STRUCTURE THERAPEUTICS INC | GPCR | 4,100,000 | $71.0M | 2.30% |
| 15 | 89BIO INC | 282559103 | 9,316,333 | $67.7M | 2.19% |
| 16 | NURIX THERAPEUTICS INC | NRIX | 5,500,000 | $65.3M | 2.12% |
| 17 | GERON CORP | GERN | 38,176,251 | $60.7M | 1.97% |
| 18 | SAREPTA THERAPEUTICS INC | SRPT | 899,731 | $57.4M | 1.86% |
| 19 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 1,350,000 | $48.9M | 1.58% |
| 20 | ANI PHARMACEUTICALS INC | ANIP | 700,000 | $46.9M | 1.52% |
| 21 | DIANTHUS THERAPEUTICS INC | DNTH | 2,357,702 | $42.8M | 1.38% |
| 22 | IMMUNOCORE HLDGS PLC | IMCR | 1,411,402 | $41.9M | 1.36% |
| 23 | CELLDEX THERAPEUTICS INC NEW | CLDX | 2,000,000 | $36.3M | 1.18% |
| 24 | MAZE THERAPEUTICS INC | MAZE | 3,269,126 | $36.0M | 1.17% |
| 25 | AMGEN INC | AMGN | 113,035 | $35.2M | 1.14% |
| 26 | XENON PHARMACEUTICALS INC | XENE | 1,000,000 | $33.5M | 1.09% |
| 27 | EDGEWISE THERAPEUTICS INC | EWTX | 1,400,000 | $30.8M | 1.00% |
| 28 | METSERA INC | 59267L107 | 1,094,408 | $29.8M | 0.96% |
| 29 | VAXCYTE INC | PCVX | 750,000 | $28.3M | 0.92% |
| 30 | AUTOLUS THERAPEUTICS PLC | AUTL | 17,849,482 | $27.7M | 0.90% |
| 31 | BICARA THERAPEUTICS INC | BCAX | 2,000,000 | $26.1M | 0.84% |
| 32 | COMPASS PATHWAYS PLC | CMPS | 8,859,648 | $25.3M | 0.82% |
| 33 | TECTONIC THERAPEUTIC INC | TECX | 1,401,938 | $24.8M | 0.80% |
| 34 | ABIVAX SA | AAVXF | 3,579,209 | $22.4M | 0.72% |
| 35 | MBX BIOSCIENCES INC | MBX | 3,018,935 | $22.3M | 0.72% |
| 36 | GH RESEARCH PLC | GHRS | 2,000,000 | $22.1M | 0.71% |
| 37 | DYNE THERAPEUTICS INC | DYN | 2,000,000 | $20.9M | 0.68% |
| 38 | ENGENE HOLDINGS INC | ENGNW | 4,557,575 | $20.4M | 0.66% |
| 39 | INSMED INC | INSM | 254,751 | $19.4M | 0.63% |
| 40 | GALAPAGOS NV | GLPGF | 741,068 | $18.6M | 0.60% |
| 41 | SAGE THERAPEUTICS INC | 78667J108 | 2,038,845 | $16.2M | 0.52% |
| 42 | TERNS PHARMACEUTICALS INC | TERN | 5,576,558 | $15.4M | 0.50% |
| 43 | KORRO BIO INC | KRRO | 874,614 | $15.2M | 0.49% |
| 44 | ORUKA THERAPEUTICS INC | ORKA | 1,444,709 | $14.8M | 0.48% |
| 45 | MIND MEDICINE MINDMED INC | 60255C885 | 2,500,000 | $14.6M | 0.47% |
| 46 | UPSTREAM BIO INC | UPB | 2,299,567 | $14.1M | 0.46% |
| 47 | OLEMA PHARMACEUTICALS INC | OLMA | 3,442,833 | $12.9M | 0.42% |
| 48 | SEPTERNA INC | SEPN | 1,912,929 | $11.1M | 0.36% |
| 49 | NOVAVAX INC | NVAX | 1,518,182 | $9.7M | 0.32% |
| 50 | CYBIN INC | HELP | 1,529,987 | $9.7M | 0.31% |
| 51 | RAPT THERAPEUTICS INC | 75382E109 | 6,011,380 | $7.3M | 0.24% |
| 52 | PLIANT THERAPEUTICS INC | PLRX | 5,399,681 | $7.3M | 0.24% |
| 53 | AVALO THERAPEUTICS INC | AVTX | 859,876 | $6.9M | 0.22% |
| 54 | BICYCLE THERAPEUTICS PLC | BCYC | 767,016 | $6.5M | 0.21% |
| 55 | BEAM THERAPEUTICS INC | BEAM | 315,765 | $6.2M | 0.20% |
| 56 | INVIVYD INC | IVVD | 9,722,254 | $5.9M | 0.19% |
| 57 | XENCOR INC | XNCR | 549,439 | $5.8M | 0.19% |
| 58 | REGULUS THERAPEUTICS INC | 75915K309 | 3,262,564 | $5.7M | 0.18% |
| 59 | INOVIO PHARMACEUTICALS INC | INO | 3,119,162 | $5.1M | 0.16% |
| 60 | RAPPORT THERAPEUTICS INC | RAPP | 457,556 | $4.6M | 0.15% |
| 61 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $4.5M | 0.15% |
| 62 | ZURA BIO LTD | ZURA | 3,283,783 | $4.2M | 0.14% |
| 63 | ALIGOS THERAPEUTICS INC | ALGS | 444,110 | $3.7M | 0.12% |
| 64 | SPYRE THERAPEUTICS INC | SYRE | 219,015 | $3.5M | 0.11% |
| 65 | IKENA ONCOLOGY INC | 45175G108 | 2,515,513 | $3.2M | 0.10% |
| 66 | ONKURE THERAPEUTICS INC | OKUR | 523,989 | $2.3M | 0.07% |
| 67 | ALLAKOS INC | 01671P100 | 7,232,701 | $1.6M | 0.05% |
| 68 | NEUROGENE INC | NGNE | 116,660 | $1.4M | 0.04% |
| 69 | CLIMB BIO INC | CLYM | 1,040,115 | $1.3M | 0.04% |